(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
-6.35% $ 0.0590
Live Chart Being Loaded With Signals
CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific...
Stats | |
---|---|
Dzisiejszy wolumen | 1.92M |
Średni wolumen | 351 011 |
Kapitalizacja rynkowa | 12.21M |
EPS | $0 ( 2024-02-28 ) |
Następna data zysków | ( $0 ) 2024-06-03 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.980 |
ATR14 | $0.00100 (1.69%) |
Cardiex Ltd Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cardiex Ltd Finanse
Annual | 2023 |
Przychody: | $4.60M |
Zysk brutto: | $3.70M (80.33 %) |
EPS: | $-0.150 |
FY | 2023 |
Przychody: | $4.60M |
Zysk brutto: | $3.70M (80.33 %) |
EPS: | $-0.150 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $0 |
FY | 2022 |
Przychody: | $4.07M |
Zysk brutto: | $3.13M (76.85 %) |
EPS: | $-0.0989 |
Financial Reports:
No articles found.
Cardiex Ltd
CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific. The company undertakes contracts with pharmaceutical companies for the use of SphygmoCor XCEL devices; provides lab and data management services for clinical trials comprising end-to-end service that delivers clean datasets to study sponsors. It also develops home vascular health solutions, remote patient monitoring, decentralized clinical trials and solutions wearables, and medical health apps under the CONNEQT name, as well as CONNEQT Pulse device, a home-based heart health vital signs monitoring system, that measures central blood pressure, arterial waveforms, and various other proprietary arterial health parameters through its SphygmoCor technology. The company serves hospitals, clinics, research institutions and pharmaceutical companies. It has strategic collaboration agreement with LifeQ, Inc for wearable devices. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is based in Sydney, Australia.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej